Prenetics Global Limited Class A Ordinary Share (PRE)

$17.83 -0.11 (-0.61%)
Market Cap 298.70M
Revenue (ttm) 92.39M
Net Income (ttm) -58.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -63.12%
Debt to Equity Ratio 0.00
Volume 222,400
Avg Vol 241,074
Day's Range N/A - N/A
Shares Out 16.83M
Stochastic %K 20%
Beta 0.27
Analysts Strong Sell
Price Target $31.25

Company Profile

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into h...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 852 2210 9588
Address:
Unit 703-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong
ZacksSCR
ZacksSCR Apr. 17 at 10:30 PM
$PRE initiated at $30 price target. IM8 brand hit $120M ARR in 12 months. Company debt-free with $170M cash. Athlete partnerships structured as equity, not endorsement fees. https://youtu.be/IIfurXL7wtc
1 · Reply
ZacksSCR
ZacksSCR Apr. 8 at 3:27 PM
Initiating Coverage of Rapid-Growing $PRE https://buff.ly/216Ezbz
0 · Reply
focafoca99
focafoca99 Apr. 2 at 7:57 PM
$PRE Giannis Antetokounmpo is joining IM8 as a global partner and shareholder under a multi-year deal, giving the brand a much bigger athlete face.
0 · Reply
Sidoti
Sidoti Mar. 30 at 12:21 PM
New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap
0 · Reply
Sidoti
Sidoti Mar. 20 at 4:55 PM
Prenetics Global Limited ($PRE) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_1d-20z12RkKM5y8lzKf6Xw
0 · Reply
positiveguy
positiveguy Mar. 19 at 5:17 PM
$PRE PLEASE BUY IGNITON FROM GAIA . THEY HAVE NO CLUE.
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 2:46 PM
$PRE 10:17 on Mar. 16 2026 Lake Street Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $29 #tradeideas
0 · Reply
STACKD0E
STACKD0E Mar. 16 at 1:41 PM
$PRE 🙃✨
0 · Reply
rroycenyc
rroycenyc Mar. 10 at 3:40 PM
$PRE
0 · Reply
topstockalerts
topstockalerts Mar. 6 at 6:43 PM
Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months, saying the move reflects management’s belief that the current stock price undervalues the business. During Feb. 23–27, executives purchased about $1.3 million in shares on the open market at an average price of around $17.11, including roughly $750,000 bought personally by CEO Danny Yeung. Combined with $1.45 million purchased after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180–$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. The company also completed several strategic divestitures in 2025 and early 2026. $PRE
0 · Reply
Latest News on PRE
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Mar 24, 2026, 11:00 AM EDT - 24 days ago

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

Feb 18, 2026, 9:25 AM EST - 2 months ago

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

Feb 18, 2026, 9:11 AM EST - 2 months ago

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors

Feb 17, 2026, 4:30 PM EST - 2 months ago

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors

Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Feb 13, 2026, 8:00 AM EST - 2 months ago

Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Buying bitcoin is no longer a thing for this David Beckham-backed health company

Dec 30, 2025, 3:06 PM EST - 3 months ago

Buying bitcoin is no longer a thing for this David Beckham-backed health company

MSTR

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Dec 23, 2025, 9:08 AM EST - 4 months ago

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Prenetics Announces Upcoming Conference Participation

Nov 25, 2025, 8:49 AM EST - 5 months ago

Prenetics Announces Upcoming Conference Participation

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Nov 24, 2025, 7:30 AM EST - 5 months ago

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Nov 14, 2025, 8:35 AM EST - 5 months ago

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

Nov 10, 2025, 7:24 AM EST - 5 months ago

Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History

EXOD

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Nov 4, 2025, 8:00 AM EST - 5 months ago

Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Oct 31, 2025, 8:31 AM EDT - 6 months ago

Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Oct 29, 2025, 4:05 PM EDT - 6 months ago

Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 28, 2025, 2:20 PM EDT - 6 months ago

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Oct 27, 2025, 10:12 AM EDT - 6 months ago

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Oct 8, 2025, 8:04 AM EDT - 6 months ago

Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Sep 30, 2025, 8:00 AM EDT - 7 months ago

Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

Sep 12, 2025, 8:30 AM EDT - 7 months ago

Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Jun 26, 2025, 4:30 AM EDT - 10 months ago

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

Jun 18, 2025, 8:45 AM EDT - 10 months ago

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

Jun 18, 2025, 7:50 AM EDT - 10 months ago

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Mar 18, 2025, 8:30 AM EDT - 1 year ago

Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Mar 5, 2025, 8:30 AM EST - 1 year ago

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Feb 11, 2025, 8:30 AM EST - 1 year ago

Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Jan 15, 2025, 8:30 AM EST - 1 year ago

Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Dec 5, 2024, 8:30 AM EST - 1 year ago

Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services

Prenetics Announces Participation in December Investor Conferences

Dec 4, 2024, 4:05 PM EST - 1 year ago

Prenetics Announces Participation in December Investor Conferences

Prenetics Announces Third Quarter 2024 Financial Results

Nov 27, 2024, 8:30 AM EST - 1 year ago

Prenetics Announces Third Quarter 2024 Financial Results

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:57 AM EST - 1 year ago

MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Nov 18, 2024, 6:00 AM EST - 1 year ago

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Jul 11, 2024, 8:30 AM EDT - 1 year ago

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Jul 1, 2024, 8:30 AM EDT - 1 year ago

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

Prenetics Announces First Quarter 2024 Financial Results

Jun 18, 2024, 8:30 AM EDT - 1 year ago

Prenetics Announces First Quarter 2024 Financial Results

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Apr 1, 2024, 7:30 AM EDT - 2 years ago

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Feb 9, 2024, 9:25 AM EST - 2 years ago

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

Prenetics Announces Third Quarter 2023 Financial Results

Nov 20, 2023, 6:00 AM EST - 2 years ago

Prenetics Announces Third Quarter 2023 Financial Results

Prenetics Global Limited Announces Reverse Stock Split

Nov 1, 2023, 6:00 AM EDT - 2 years ago

Prenetics Global Limited Announces Reverse Stock Split

Prenetics Announces Second Quarter 2023 Financial Results

Sep 15, 2023, 6:58 AM EDT - 2 years ago

Prenetics Announces Second Quarter 2023 Financial Results

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Jun 26, 2023, 2:18 AM EDT - 3 years ago

Prenetics CEO discusses $200 million JV for early cancer detection breakthrough

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Jun 25, 2023, 8:45 PM EDT - 3 years ago

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening

Prenetics Announces First Quarter 2023 Financial Results

Jun 5, 2023, 7:00 AM EDT - 3 years ago

Prenetics Announces First Quarter 2023 Financial Results

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Mar 14, 2023, 8:49 AM EDT - 3 years ago

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Mar 2, 2023, 7:00 AM EST - 3 years ago

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Feb 2, 2023, 4:01 PM EST - 3 years ago

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Jan 19, 2023, 5:00 AM EST - 3 years ago

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

Prenetics Global's stock rallies 82%

Jan 10, 2023, 8:30 AM EST - 3 years ago

Prenetics Global's stock rallies 82%

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Jan 10, 2023, 6:00 AM EST - 3 years ago

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

ZacksSCR
ZacksSCR Apr. 17 at 10:30 PM
$PRE initiated at $30 price target. IM8 brand hit $120M ARR in 12 months. Company debt-free with $170M cash. Athlete partnerships structured as equity, not endorsement fees. https://youtu.be/IIfurXL7wtc
1 · Reply
ZacksSCR
ZacksSCR Apr. 8 at 3:27 PM
Initiating Coverage of Rapid-Growing $PRE https://buff.ly/216Ezbz
0 · Reply
focafoca99
focafoca99 Apr. 2 at 7:57 PM
$PRE Giannis Antetokounmpo is joining IM8 as a global partner and shareholder under a multi-year deal, giving the brand a much bigger athlete face.
0 · Reply
Sidoti
Sidoti Mar. 30 at 12:21 PM
New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap
0 · Reply
Sidoti
Sidoti Mar. 20 at 4:55 PM
Prenetics Global Limited ($PRE) Management Team presented at the Sidoti Small-Cap Virtual Conference this week. Watch the replay here: https://sidoti.zoom.us/webinar/register/WN_1d-20z12RkKM5y8lzKf6Xw
0 · Reply
positiveguy
positiveguy Mar. 19 at 5:17 PM
$PRE PLEASE BUY IGNITON FROM GAIA . THEY HAVE NO CLUE.
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 2:46 PM
$PRE 10:17 on Mar. 16 2026 Lake Street Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $29 #tradeideas
0 · Reply
STACKD0E
STACKD0E Mar. 16 at 1:41 PM
$PRE 🙃✨
0 · Reply
rroycenyc
rroycenyc Mar. 10 at 3:40 PM
$PRE
0 · Reply
topstockalerts
topstockalerts Mar. 6 at 6:43 PM
Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months, saying the move reflects management’s belief that the current stock price undervalues the business. During Feb. 23–27, executives purchased about $1.3 million in shares on the open market at an average price of around $17.11, including roughly $750,000 bought personally by CEO Danny Yeung. Combined with $1.45 million purchased after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180–$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. The company also completed several strategic divestitures in 2025 and early 2026. $PRE
0 · Reply
topstockalerts
topstockalerts Mar. 6 at 4:38 PM
Prenetics Global Limited announced a $40 million share buyback program authorized by its board for the next 12 months. The health sciences company said the move reflects management’s view that the current share price does not reflect the business’s underlying value. During Feb. 23–27, Prenetics executives bought about $1.3 million in shares on the open market at an average price of roughly $17.11, including about $750,000 purchased personally by CEO Danny Yeung. Combined with $1.45 million in purchases after the November 2025 earnings release, executives have invested about $2.75 million of personal capital in company stock. Prenetics reported about $164 million in adjusted liquidity as of March 1 with no debt. Its premium health and longevity brand IM8 targets $180–$200 million in revenue in 2026 and adjusted EBITDA profitability by Q4 2027. $PRE
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 2 at 11:33 AM
$PRE Current Stock Price: $16.94 Contracts to trade: $17.5 PRE Mar 20 2026 Call Entry: $0.77 Exit: $1.26 ROI: 64% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 20 at 3:40 PM
$PRE RSI: 45.40, MACD: 0.7651 Vol: 1.28, MA20: 19.79, MA50: 17.58 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Sidoti
Sidoti Feb. 20 at 2:09 PM
New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 18 at 3:38 PM
$PRE Q4 '25 Earnings Results & Recap Prenetics reaffirms its 2026 IM8 revenue guidance of $180M to $200M, implying $250M to $300M in ARR by year-end, while targeting an adjusted EBITDA loss broadly similar to 2025.
0 · Reply
rroycenyc
rroycenyc Feb. 18 at 2:35 PM
$PRE
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 18 at 2:26 PM
$PRE Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
0 · Reply
bread90
bread90 Feb. 17 at 1:27 PM
$PRE
0 · Reply
Sidoti
Sidoti Feb. 13 at 11:36 AM
New research on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap
0 · Reply
allegedlyshane2
allegedlyshane2 Jan. 29 at 5:43 PM
$PRE new high
0 · Reply
Sidoti
Sidoti Jan. 29 at 2:01 PM
See a recording of these healthcare management teams present at our January conference. $OPTHF $PHIO $PRE $SBC https://www.meetmax.com/sched/event_129449/conference_presentations.html
0 · Reply
kingkm70
kingkm70 Jan. 23 at 1:14 AM
$PRE All time high - I guess that's good right?
1 · Reply